1. Home
  2. BIVI vs TAIT Comparison

BIVI vs TAIT Comparison

Compare BIVI & TAIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • TAIT
  • Stock Information
  • Founded
  • BIVI 2013
  • TAIT 1989
  • Country
  • BIVI United States
  • TAIT United States
  • Employees
  • BIVI N/A
  • TAIT N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • TAIT Electronic Components
  • Sector
  • BIVI Health Care
  • TAIT Technology
  • Exchange
  • BIVI Nasdaq
  • TAIT Nasdaq
  • Market Cap
  • BIVI 18.8M
  • TAIT 15.7M
  • IPO Year
  • BIVI N/A
  • TAIT 1995
  • Fundamental
  • Price
  • BIVI $0.86
  • TAIT $2.32
  • Analyst Decision
  • BIVI Strong Buy
  • TAIT
  • Analyst Count
  • BIVI 1
  • TAIT 0
  • Target Price
  • BIVI $30.00
  • TAIT N/A
  • AVG Volume (30 Days)
  • BIVI 230.4K
  • TAIT 5.7K
  • Earning Date
  • BIVI 05-13-2025
  • TAIT 05-14-2025
  • Dividend Yield
  • BIVI N/A
  • TAIT 8.18%
  • EPS Growth
  • BIVI N/A
  • TAIT N/A
  • EPS
  • BIVI N/A
  • TAIT 0.15
  • Revenue
  • BIVI N/A
  • TAIT $4,141,000.00
  • Revenue This Year
  • BIVI N/A
  • TAIT N/A
  • Revenue Next Year
  • BIVI N/A
  • TAIT N/A
  • P/E Ratio
  • BIVI N/A
  • TAIT $16.49
  • Revenue Growth
  • BIVI N/A
  • TAIT N/A
  • 52 Week Low
  • BIVI $0.80
  • TAIT $2.36
  • 52 Week High
  • BIVI $7.50
  • TAIT $3.24
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 36.17
  • TAIT 30.03
  • Support Level
  • BIVI $0.80
  • TAIT $2.49
  • Resistance Level
  • BIVI $1.00
  • TAIT $2.60
  • Average True Range (ATR)
  • BIVI 0.10
  • TAIT 0.08
  • MACD
  • BIVI 0.01
  • TAIT -0.02
  • Stochastic Oscillator
  • BIVI 29.24
  • TAIT 0.00

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

Share on Social Networks: